Burggraaf et al. [16] also reported that patients with RA had higher baseline ApoB48 levels than controls and that the accumulation of atherogenic chylomicron remnants could contribute to the risk of cardiovascular events in affected patients. The gene discussed is APOB; the disease is rheumatoid arthritis.